Activating the GPR133 receptor with a small molecule can rebuild bone from within, offering a new direction for osteoporosis ...
A Hall-effect sensor is a transducer that converts a magnetic field directly into a usable electrical voltage. It enables ...
By fusing enzyme fragments to antibodies, researchers from the Institute of Science Tokyo, in Japan, developed an innovative enzyme switch called "Switchbody," which is activated when bound to its ...
Presentation of MyPEAK-1 Data and the American Heart Association Scientific Sessions Showed Consistent, Deeper, and Durable ...
Study Finds on MSN
Cancer Rates Drop After Age 85: Stanford Study Reveals Why Aging Protects Against Tumors
Study shows aging tissues resist tumors even as mutations accumulate. Reveals why cancer rates decline after 85 and opens treatment paths.
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced third quarter ...
The FDA has put a clinical hold on a Tenaya Therapeutics gene therapy study | The FDA has put a clinical hold on a Tenaya ...
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery CoTx-101 represents a potential breakthrough for ...
In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the reach of CAR T-cell therapies into solid tumor indications.
Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...
The three researchers are victims of a frame-up. The arrests are part of a campaign by the Justice Department and FBI to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results